Rich production media as a platform for CHO cell line development

被引:0
|
作者
Yong Jae Kim
Sang Kyul Han
Seongtae Yoon
Chan Wha Kim
机构
[1] Korea University,Department of Biotechnology, College of Life Sciences and Biotechnology
[2] GC Pharma R &D Center,undefined
[3] GC Pharma,undefined
来源
AMB Express | / 10卷
关键词
Cell line development; Chemically defined media; Single cell isolation; Semi-solid media; Chinese hamster ovary cell;
D O I
暂无
中图分类号
学科分类号
摘要
Recent cell culture media for mammalian cells can be abundantly formulated with nutrients supporting production, but such media can be limited to use in host cell culture, transfection, cell cloning, and cell growth under the low cell density conditions. In many cases, appropriate platform media are used for cell line development, and then replaced with rich media for production. In this study, we demonstrate rich chemically defined media for Chinese hamster ovary (CHO) cells that are suitable as basal media both for cell line development and for final production of culture process. Set up for transfection, semi-solid media optimization, mini-pool screening, and single cell cloning media development were performed, and final clones were obtained with higher productivity in fed-batch culture mode using rich formulated media comparing with lean formulated media. Developed methods may remove the requirements for cell adaptation to production media after cell line development, and relieve the clonality issues associated with changing the culture media. Furthermore, established methods have advantages over traditional approaches, including saving resources and decreasing the time and the effort required to optimize the production process.
引用
收藏
相关论文
共 50 条
  • [21] Development of a robust fed-batch cho cell culture platform to optimize monoclonal antibody production.
    Garza, PA
    Kopelev, C
    Osborne, D
    Reid, M
    Torres, J
    Gaya, M
    Vargas, N
    Noe, W
    Chang, YHD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U191 - U191
  • [22] Benchmarking of commercially available CHO cell culture media for antibody production
    David Reinhart
    Lukas Damjanovic
    Christian Kaisermayer
    Renate Kunert
    Applied Microbiology and Biotechnology, 2015, 99 : 4645 - 4657
  • [23] Benchmarking of commercially available CHO cell culture media for antibody production
    David Reinhart
    Christian Kaisermayer
    Lukas Damjanovic
    Renate Kunert
    BMC Proceedings, 7 (Suppl 6)
  • [24] Benchmarking of commercially available CHO cell culture media for antibody production
    Reinhart, David
    Damjanovic, Lukas
    Kaisermayer, Christian
    Kunert, Renate
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2015, 99 (11) : 4645 - 4657
  • [25] Mapping and partial characterization of proteases expressed by a CHO production cell line
    Sandberg, H.
    Lutkemeyer, D.
    Kuprin, S.
    Wrangel, M.
    Almstedt, A.
    Persson, P.
    Ek, V.
    Milkaelsson, M.
    BIOTECHNOLOGY AND BIOENGINEERING, 2006, 95 (05) : 961 - 971
  • [26] Mechanistic modeling and applications for CHO cell culture development and production
    Sha, Sha
    Huang, Zhuangrong
    Wang, Zhao
    Yoon, Seongkyu
    CURRENT OPINION IN CHEMICAL ENGINEERING, 2018, 22 : 54 - 61
  • [27] Accelerated generation of high-yielding monoclonal stable CHO cell lines using a ClonePix-based cell line development platform
    Agarwal, Kitty
    Kachole, Mukta
    McKenzie, Angela
    Smedley, James
    Shukla, Abhinav
    Hussain, Althaf
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [28] Pilot scale production of human Prothrombin using a recombinant CHO cell line
    Lütkemeyer, D
    Heidemann, R
    Tebbe, H
    Gudermann, F
    Lehmann, J
    Schmidt, M
    Raditsch, M
    ANIMAL CELL TECHNOLOGY: PRODUCTS FROM CELLS, CELLS AS PRODUCTS, 1999, : 99 - 101
  • [29] miRNA engineering of CHO cells facilitates production of difficult-to-express proteins and increases success in cell line development
    Fischer, Simon
    Marquart, Kim F.
    Pieper, Lisa A.
    Fieder, Juergen
    Gamer, Martin
    Gorr, Ingo
    Schulz, Patrick
    Bradl, Harald
    BIOTECHNOLOGY AND BIOENGINEERING, 2017, 114 (07) : 1495 - 1510
  • [30] CHO-DHFR cell line development platform: Application of Clonepix and Automated Mini Bioreactor (AMBR) technologies to meet accelerated timelines
    Venkata R Mangalampalli
    Dyane Wycuff
    Mingzhong Chen
    David Berlinger
    Elizabeth H Scheideman
    Amritha Menon
    Guilia Fabozzi
    Althaf Hussain
    Richard M Schwartz
    BMC Proceedings, 9 (Suppl 9)